Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Xtacy Therapeutics ( (TSE:LOAN) ) has shared an announcement.
Pegasus Mercantile Inc., previously known as Xtacy Therapeutics Corp., announced the consolidation of its common shares, effective January 31, 2025, at a ratio of one post-consolidation share for every five pre-consolidation shares. This move, while maintaining the company’s name and trading symbol, is expected to streamline share trading on the Canadian Securities Exchange and potentially enhance company value for shareholders.
More about Xtacy Therapeutics
Pegasus Mercantile is a prospect generator that supports high growth companies with financial, operational, and management assistance, focusing on the rapidly expanding market for consumer products, particularly in the global wellness and healthcare sectors.
YTD Price Performance: -15.00%
Average Trading Volume: 100,891
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.2M
Find detailed analytics on LOAN stock on TipRanks’ Stock Analysis page.